Twelve Below
$50M Fund I
Twelve Below, a NYC-focused seed-stage fund, has raised $50M for its inaugural fund. The firm was founded by NYC investing veteran Taylor Greene, who previously held roles at Collaborative Fund and Lerer Hippeau. The fund, which was founded in July, already counts companies like Acrrue Savings, Otto, Dutech, and Opentrons in its portfolio.
TQ Ventures
$12.5M Early Fund III First Close | $37.5M Growth Fund III First Close
TQ Ventures, the early-stage and growth investment firm, has led the first close for two new funds according to a recent SEC filing. The filing indicates that the fund offering for the early fund is $125M and $375M for the growth fund, both closes had one hundred LPs. TQ Ventures was founded by Andrew Marks, Schuster Tanger, and Scooter Braun in 2018. The portfolio includes Latch, Vertical Finance, Liquid IV, Right Rice, Ro, Mos, Modern Treasury, TrialSpark, Zype, Current, Clubhouse, and Noom. The company closed Fund II in 2019.
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery. The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.). Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency! In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on. Get in on this rapidly growing startup and learn how you can invest today
Grace Isford
Principal | Lux Capital
Grace Isford has joined Lux Capital as a Principal with a focus on Web3, data infrastructure, and AI/ML. She joins the firm after having spent 5+ years at Canvas Ventures, where she invested in companies like airvet, Flowspace, Conduktor, Flyhomes, and Robocorp. Isford is a graduate of Stanford.
Imaginary Ventures
$270M Fund III | $175M Growth Fund III
Imaginary, the early-stage and growth investment firm focused on the intersection of retail and tech, has closed two new funds according to a recent SEC filing. The filing indicates that the main fund has seventy-one LPs and the growth fund has sixty-six backers. Imaginary Ventures was founded by Natalie Massenet and Nick Brown in 2018. The portfolio includes Skims, SIMULATE, Glossier, Keeps, HUM Nutrition, and NuORDER. The company closed Fund II in 2019.
Make an impact on your bottom line and drive leads!
The AlleyWatch audience is driving progress and innovation on a global scale. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including strategic brand placement, lead generation, and thought leadership in front of an audience that comprises the vast majority of key decision-makers in the NYC business community and beyond. Learn more about advertising to NYC Tech, at scale.
J Ventures
Fund II Filing – $45M
J Ventures, an early-stage tech fund, is raising its second fund according to a recent SEC filing. The filing indicates that the total offering is $45M. J Ventures was founded by John Nordin and Joshua Jacobson in 2019. The firm’s portfolio includes names like bbot, Brighhire, Ro, Clear, Ramp, Sprout, and Troops.
Black Opal Ventures
Fund I Filing – $120M
Black Opal Ventures, a healthtech-focused investment fund, is raising its first fund according to a recent SEC filing. The filing indicates that the total offering is for $120M. J Ventures was founded by physician-turned-investor Tara Bishop. The firm’s portfolio includes names like bbot, Brighhire, Ro, Clear, Ramp, Sprout, and Troops.
You are seconds away from signing up for the hottest list in NYC Tech!
Sign up today
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery.
The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.).
Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency!
In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 Ð this is an investment you don’t want to miss out on.
Credit: Source link
